Ligand validation:6HR2

EDO: 1,2-ETHANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6HR2_EDO_H_201	36%	81%	0.143	0.837	0.57	0.25	-	-	0	0	100%	1
6HR2_EDO_F_302	33%	77%	0.163	0.843	0.55	0.37	-	-	0	0	100%	1
2IZV_EDO_A_1431	93%	71%	0.079	0.976	0.79	0.3	-	-	0	0	100%	1
6HAY_EDO_D_201	68%	76%	0.132	0.945	0.5	0.45	-	-	0	0	100%	1
7JTO_EDO_L_702	62%	86%	0.158	0.952	0.26	0.45	-	-	1	0	100%	1
7S4E_EDO_A_1502	54%	97%	0.116	0.881	0.19	0.14	-	-	0	0	100%	1
8BB5_EDO_C_303	52%	96%	0.2	0.96	0.09	0.28	-	-	0	0	100%	1
4KXW_EDO_A_1003	100%	73%	0.033	0.993	0.64	0.4	-	-	0	0	100%	1
7CJO_EDO_B_1210	100%	83%	0.038	0.99	0.47	0.32	-	-	0	0	100%	1
4O78_EDO_A_202	100%	86%	0.043	0.992	0.4	0.33	-	-	0	0	100%	1
6QRS_EDO_A_401	100%	83%	0.045	0.991	0.47	0.31	-	-	0	0	100%	1
1EB6_EDO_A_1180	100%	64%	0.041	0.986	0.62	0.72	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.